ZA961795B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number: ZA961795B
Authority: ZA; South Africa
Prior art keywords: pharmaceuticals; bioprecursor; hhv; medicament; infection
Prior art date: 1995-03-07

Application number

ZA961795A

Other languages

English (en)

Inventor

Klaus Max Esser

Richard Anthony Vere Hodge

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-07

Filing date

1996-03-05

Publication date

1996-11-25

1996-03-05 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

1996-11-25 Publication of ZA961795B publication Critical patent/ZA961795B/xx

Links

239000003814 drug Substances 0.000 title abstract 2
229910019142 PO4 Inorganic materials 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010066435 human herpesvirus 8 infection Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
-1 phosphate ester Chemical class 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Biotechnology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA961795A 1995-03-07 1996-03-05 Pharmaceuticals ZA961795B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9504497.0A GB9504497D0 (en)	1995-03-07	1995-03-07	Pharmaceuticals

Publications (1)

Publication Number	Publication Date
ZA961795B true ZA961795B (en)	1996-11-25

Family

ID=10770731

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA961795A ZA961795B (en)	1995-03-07	1996-03-05	Pharmaceuticals

Country Status (22)

Country	Link
US (1)	US6489330B1 (de)
EP (1)	EP0814813B1 (de)
JP (2)	JPH11501625A (de)
KR (1)	KR19980702833A (de)
CN (1)	CN1138545C (de)
AT (1)	ATE254919T1 (de)
AU (1)	AU701739B2 (de)
BR (1)	BR9607663A (de)
CA (1)	CA2214406C (de)
CY (1)	CY2525B1 (de)
CZ (1)	CZ293470B6 (de)
DE (1)	DE69630876T2 (de)
DK (1)	DK0814813T3 (de)
ES (1)	ES2211949T3 (de)
GB (1)	GB9504497D0 (de)
HU (1)	HU226005B1 (de)
NO (1)	NO317733B1 (de)
NZ (1)	NZ303951A (de)
PT (1)	PT814813E (de)
TR (1)	TR199700921T1 (de)
WO (1)	WO1996027378A2 (de)
ZA (1)	ZA961795B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010503710A (ja)	2006-09-18	2010-02-04	ラプトールファーマシューティカルインコーポレイテッド	受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
EP2274042A4 (de) *	2008-04-11	2012-03-14	Epiphany Biosciences Inc	Behandlung und/oder verhinderung multipler sklerose
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0141927B1 (de) *	1983-08-18	1991-10-30	Beecham Group Plc	Antivirale Guanin-Derivate
EP0182024B1 (de) *	1984-09-20	1991-04-03	Beecham Group Plc	Purin-Derivate und ihre pharmazeutische Verwendung
EP0216459B1 (de) *	1985-07-27	1990-05-16	Beecham Group Plc	9-Substituierte Guaninmonohydrate
CA2042931A1 (en)	1990-05-24	1991-11-25	Robert Zahler	Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en)	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment

1995
- 1995-03-07 GB GBGB9504497.0A patent/GB9504497D0/en active Pending
1996
- 1996-03-05 CA CA2214406A patent/CA2214406C/en not_active Expired - Fee Related
- 1996-03-05 TR TR97/00921T patent/TR199700921T1/xx unknown
- 1996-03-05 AT AT96907360T patent/ATE254919T1/de not_active IP Right Cessation
- 1996-03-05 NZ NZ303951A patent/NZ303951A/xx not_active IP Right Cessation
- 1996-03-05 JP JP8526607A patent/JPH11501625A/ja not_active Withdrawn
- 1996-03-05 CZ CZ19972831A patent/CZ293470B6/cs not_active IP Right Cessation
- 1996-03-05 DK DK96907360T patent/DK0814813T3/da active
- 1996-03-05 BR BR9607663A patent/BR9607663A/pt not_active Application Discontinuation
- 1996-03-05 AU AU51022/96A patent/AU701739B2/en not_active Ceased
- 1996-03-05 DE DE69630876T patent/DE69630876T2/de not_active Expired - Fee Related
- 1996-03-05 ZA ZA961795A patent/ZA961795B/xx unknown
- 1996-03-05 WO PCT/EP1996/000933 patent/WO1996027378A2/en not_active Ceased
- 1996-03-05 KR KR1019970706240A patent/KR19980702833A/ko not_active Ceased
- 1996-03-05 HU HU9800272A patent/HU226005B1/hu not_active IP Right Cessation
- 1996-03-05 CN CNB961937939A patent/CN1138545C/zh not_active Expired - Fee Related
- 1996-03-05 ES ES96907360T patent/ES2211949T3/es not_active Expired - Lifetime
- 1996-03-05 PT PT96907360T patent/PT814813E/pt unknown
- 1996-03-05 EP EP96907360A patent/EP0814813B1/de not_active Expired - Lifetime
1997
- 1997-09-05 NO NO19974101A patent/NO317733B1/no not_active IP Right Cessation
1999
- 1999-12-29 US US09/473,888 patent/US6489330B1/en not_active Expired - Lifetime
2005
- 2005-05-26 CY CY0500032A patent/CY2525B1/xx unknown
2007
- 2007-08-08 JP JP2007206799A patent/JP2007297412A/ja active Pending

Also Published As

Publication number	Publication date
CZ293470B6 (cs)	2004-05-12
KR19980702833A (ko)	1998-08-05
NO974101D0 (no)	1997-09-05
HUP9800272A3 (en)	2000-12-28
CA2214406C (en)	2010-12-21
HUP9800272A2 (hu)	2000-05-28
NO317733B1 (no)	2004-12-13
DE69630876D1 (de)	2004-01-08
JPH11501625A (ja)	1999-02-09
TR199700921T1 (xx)	1998-02-21
EP0814813A2 (de)	1998-01-07
ATE254919T1 (de)	2003-12-15
HK1004373A1 (en)	1998-11-27
GB9504497D0 (en)	1995-04-26
HU226005B1 (en)	2008-02-28
EP0814813B1 (de)	2003-11-26
DK0814813T3 (da)	2004-03-22
WO1996027378A3 (en)	1997-01-16
BR9607663A (pt)	1998-06-16
CN1183722A (zh)	1998-06-03
MX9706759A (es)	1997-11-29
CN1138545C (zh)	2004-02-18
US6489330B1 (en)	2002-12-03
NZ303951A (en)	1999-07-29
PT814813E (pt)	2004-04-30
CY2525B1 (en)	2006-02-08
ES2211949T3 (es)	2004-07-16
CA2214406A1 (en)	1996-09-12
JP2007297412A (ja)	2007-11-15
AU5102296A (en)	1996-09-23
WO1996027378A2 (en)	1996-09-12
CZ283197A3 (cs)	1998-02-18
NO974101L (no)	1997-09-05
DE69630876T2 (de)	2004-09-02
AU701739B2 (en)	1999-02-04

Publication	Publication Date	Title
ZA95631B (en)	1995-10-05	Prolineamide derivatives
GEP20002298B (en)	2000-11-25	Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
NZ308518A (en)	2000-01-28	Antibacterial cephalosporins
BR9506552A (pt)	1997-10-28	Método de inibição de integrase retroviral
PT736029E (pt)	2006-05-31	Sulfamatos de pseudofructopiranose anticonvulsivos
GB9504497D0 (en)	1995-04-26	Pharmaceuticals
GB9323404D0 (en)	1994-01-05	Pharmaceuticals
KR930702978A (ko)	1993-11-29	인식력 장애의 치료
IL111138A (en)	1997-04-15	Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9323403D0 (en)	1994-01-05	Pharmaceuticals
NO167982C (no)	1992-01-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
GR3034062T3 (en)	2000-11-30	Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
AU1494395A (en)	1995-09-28	The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
MX9709438A (es)	1998-06-30	Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.
MX9704336A (es)	1997-09-30	Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.